Ophthalmic release of in situ gel Ciprofloxacin HCl based on combination of Hypromellose and HPC

Yoga Windhu Wardhana, Wieke Budiati, Rizky Dwi Oktavia, Kalista Tritama Widyanti, Insan Sunan Kurniawansyah, Yedi Herdiana

Abstract

The development for ophthalmic delivery was purposed to achieve optimum drug loading for ocular therapeutic benefits. An adequate dose of the drug is needed to absorb in the conjunctival sac to take effect. In situ gel preparation was expected to provide these needs with the polymer aid that makes the droplets suddenly coagulate in the eye area to maintain the drug dose. The in situ gel dosage form is desired to overcome the poor bioavailability of conventional ciprofloxacin HCl eye drops on the market. Thus, this work was studied using two cellulose polymers such as hydroxyl propyl cellulose (HPC) and hydroxypropyl methylcellulose (HMPC) as a gelling forming agent.  The effect of the in situ ophthalmic quality of the gel due to the two individual polymers separately and their combined use was investigated. The in situ gel quality includes the ability of gel-forming under the influence of varying temperature and stirring frequency difference (as a rheological study) was tested together with the drug release model model. Other ophthalmic preparation quality parameters such as clarity, pH measurement, drug content determination, sterility, and antibacterial activity have been evaluated. However, overall in situ gel formulation developed was of better quality compared to the conventional one. Consideration of the choice of cellulose derivative polymer type is seen to affect the quality of controlled release kinetics models.

Keywords: Ophthalmic gel, Ciprofloxacin HCl, HPMC, HPC, Drug release kinetics

 

Full Text:

PDF HTML

References

Abdassah, M., Wardhana, Y.W., Rusdiana, T., Yordan, M.Z.A., Anggraini, F.D., Tedjasaputra, M.G. (2016). Kinetic Study on Extended Release of Theophylline Caplet with Different Brands Hypromellose Matrix. Bulletin of Pharm Res 6(1), 1–6.

Al-Kassas, R.S., El-Khatib, M.M. (2009). Ophthalmic Controlled Release In Situ Gelling Systems for Ciprofloxacin Based on Polymeric Carriers. Drug Delivery 16(3), 145–152.

Dash, S., Murthy, P.N., Nath, L., and Chowdhury, P. (2010). Kinetic Modeling on Drug Release From Controlled Drug Delivery Systems. Acta Poloniae Pharmaceutica–Drug Research 67(3), 217–223.

Jain, S.P., Shah, S.P., Rajadhyaksha, N.S., Singh, P.S.P.P., Amin, P.D. (2008). In Situ Ophthalmic Gel of Ciprofloxacin Hydrochloride for Once a Day Sustained Delivery. Drug Development and Industrial Pharmacy 34, 445–452.

Kurniawansyah, I.S., Rusdiana, T., Wahab, H.A., Subarnas, A. (2019). In Situ Ophthalmic Gel With Ion Activated System. Int J App Pharm 11(4), 15–18.

Kurniawansyah, I.S., Sopyan, I., Wardhana, Y.W., and Gunasekaran, M. (2018). Formulation and Evaluation of Chloramphe-nicol Hydrogel Ophthalmic Preparation J Young Pharm 10(2) Suppl, s73–78.

Kurniawansyah, I.S., Sopyan, I., Wathoni, N., Fillah, D.L., Praditya, R.U. (2018). Application and Characterization of In Situ Gel. Int J App Pharm. 10(6), 34–37.

LeBel, M., (1988) Ciprofloxacin: Chemistry, Mechanism of Action, Resistance, Antimicrobial Spectrum, Pharmacokinetics, Clinical Trials, and Adverse Reactions. Pharmacotherapy 8(1), 3–30.

Makwana, S.B., Patel, V.A., and Parmar, S.J. (2015) Development and Characterization of In-Situ Gel for Ophthalmic Formulation Containing Ciprofloxacin Hydrochloride. Results in Pharma Sciences 6, 1–6.

Ministry of Health RI. Indonesian Pharmacopoeia. 5th ed. Jakarta. 2014

Rathor, K.S. (2010). In Situ Gelling Opthalmic Drug Delivery System: An Overview. Int J Pharm Pharm Sci 2, 30–34.

Rowe, R.C., Sheskey, P.J., and Quinn, M.E. (2009). Handbook of Pharmaceutical Excipients. Sixth Edition. London: Pharmaceutical Press. 317–319.

Sharma, A., Sharma, J., Kaur, R., and Saini, V. (2014). Development and Characterization of In Situ Oral Gel of Spiramycin. BioMed Research International Vol. 2014, 1–7.

Sharma, P.C., Jain, A., Jain, S., Pahwa, R., and Shahar, Y.M. (2010). Ciprofloxacin: review on developments in synthetic, analytical, and medicinal aspects, Journal of Enzyme Inhibition and Medicinal Chemistry 25(4), 577–589.

The United States pharmacopeia and National Formulary (USP 32 – NF 27) (2009). Rockville (MD): United States Pharmacopeial Convention, Inc.

Varshosaz, J., Tabbakhian, M., and Salmani, Z. (2008). Designing of a Thermosensitive Chitosan/ Poloxamer In Situ Gel for Ocular Delivery of Ciprofloxacin. The Open Drug Delivery Journal 2, 61- 70.

Vigani, B., Faccendini, A., Rossi, S., Sandri, G., Bonferoni, M.C., Gentile, M., and Ferrari, F. (2019). Development of a Mucoadhesive and In Situ GellingFormulation Based on κ-Carrageenan for Applicationon Oral Mucosa and Esophagus Walls. I. A Functional In Vitro Characterization. Mar Drugs 17(112), 1 – 16.

Zhu, L., Ao, J., and Li, P. (2015). A Novel in Situ Gel Base of Deacetylase Gellan Gum for Sustained Ophthalmic Drug Delivery of Ketotifen: In Vitro and in Vivo Evaluation. Drug Des Devel Ther 9, 3943–39

DOI: https://doi.org/10.24198/idjp.v3i3.36140

Refbacks

  • There are currently no refbacks.